Cilacar M 10 mg/50mg tablets contain an active component as Cilnidipine and metoprolol. Cilnidipine is a calcium channel blocker (CCB) that blocks calcium channels in blood vessels and the heart. It helps in lowering blood pressure. Metoprolol belongs to a class of medications known as beta-blockers. It decreases heart rate and reduces the force of contraction. This medication helps control high blood pressure and prevent angina, heart attack, and stroke. Using two medications with complementary mechanisms of action allows for lower doses of each drug, which may lead to a reduced risk of side effects commonly associated with higher doses of a single drug. By using lower doses, the likelihood of experiencing adverse effects may be diminished.

Inform the doctor about any kidney or liver-related problems. If a patient is a breastfeeding mother or planning for pregnancy, they must inform the doctor before starting this medication. While using this medication, blood pressure should be monitored regularly, and a kidney function test should be performed to note if there are any abnormal changes.

Individuals with known hypersensitivity or allergy to Cilacar M 10 mg/50mg tablets or other components of these medications should not take them. This medication should be avoided or used with extreme caution in individuals with bradycardia (abnormally slow heart rate) or heart block and patients with heart failure, as this medication can affect cardiac function. In some cases, other medications may be preferred for managing hypertension in heart failure patients.

Cilacar M 10 mg/50mg tablets are used to treat the following:

• Treatment of high blood pressure
• Helps in the prevention of angina
• Heart attack and stroke

Cilacar M 10 mg/50mg tablets provide a synergistic therapeutic effect in managing hypertension. Cildipine, a calcium channel blocker, relaxes and dilates the blood vessels, reducing peripheral resistance and improving blood flow. Metoprolol, a beta blocker that reduces the heart rate and force of contraction, reduces the workload on the heart and further contributes to blood pressure reduction.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Cilacar M 10 mg/50mg tablets reducing effectiveness by causing undesirable side effects.

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Cilacar M 10 mg/50mg tablets can be administered orally in tablet form. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider.

Cilacar M 10 mg/50mg tablets cause some side effects like all medications, although not everyone will experience them. 

Serious side effects:

• Irregular heartbeat
• Skin rash
• Hypotension

Common side effects:

• Sleepiness
• Fatigue
• Feeling warmth in face, neck, and ears
• Tiredness
• Feeling sleepy
• Headaches
• Back pain
• Stomach upset
• Nausea
• Muscle pain

When taking Cilacar M 10 mg/50mg tablets, patients should exercise caution. It is essential to adhere to the prescribed dosage and schedule the healthcare provider provides. Avoid sudden changes in position, as these medications may cause dizziness or lightheadedness, especially when standing up quickly. Patients with asthma, COPD, heart conditions, liver impairment, or diabetes should inform their healthcare provider as dose adjustments or alternative medications may be necessary. Regularly monitor blood pressure, heart rate, and liver function as the healthcare provider advises. 

Patients should consult their doctor before discontinuing or adjusting the medication, as abrupt discontinuation can lead to rebound effects. If experiencing any concerning side effects or symptoms, seek medical attention promptly. It's essential to communicate openly with the healthcare provider about any health concerns or changes in health status while on this medication to ensure safe and effective treatment.

1. Pubchem, Cilnidipine, [Revised on 31/10/2022] [Accessed on 19/07/2023], https://pubchem.ncbi.nlm.nih.gov/compound/cilnidipine
2. Lionel H. Opie. Calcium channel blockers. Drugs for the heart. 8th Edition. 2013. Page- 88-89.
3. Mukesh Madhukar Shete et al., Cilnidipine: Next Generation Calcium Channel Blocker [Revised on 26/4/2016] [Accessed on 19/07/2023]https://pubmed.ncbi.nlm.nih.gov/27734656/